The Heart Hospital Baylor Plano
Welcome,         Profile    Billing    Logout  
 15 Trials 
36 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Brown, David W
AFFECTS, NCT02973126: Heartflow

Active, not recruiting
3
270
US
FFRct and SPECT
Baylor Research Institute
Cardiovascular Abnormalities
07/22
07/22
NCT04072354 / 2019-000470-36: A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

Completed
3
463
Europe, US, RoW
SEP-363856 50mg, SEP-363856 75mg, Placebo
Otsuka Pharmaceutical Development & Commercialization, Inc.
Schizophrenia
05/23
09/23
NCT05779241: Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005

Completed
3
83
US
LYN-005, Risperidone, Risperdal
Lyndra Inc.
Schizophrenia, Schizoaffective Disorder
11/23
12/23
ASPIRE, NCT03907046: Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Recruiting
3
700
US
Apixaban, Eliquis, Aspirin
Yale University, National Institute of Neurological Disorders and Stroke (NINDS)
Intracerebral Hemorrhage, Atrial Fibrillation
04/27
04/27
INVINCIBLE-3, NCT06263231: A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults with Soft Tissue Sarcomas

Recruiting
3
333
Europe, Canada, US
INT230-6, Eribulin, Trabectedin, Pazopanib
Intensity Therapeutics, Inc., Premier Research Group plc
Sarcoma,Soft Tissue
12/27
12/28
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

Recruiting
3
630
Canada, US, RoW
ANX007, Sham Administration
Annexon, Inc.
Geographic Atrophy
10/26
10/27
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
NCT04109950 / 2019-000696-16: A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia

Terminated
3
463
Europe, US, RoW
SEP-363856
Otsuka Pharmaceutical Development & Commercialization, Inc., Sunovion Pharmaceuticals Inc.
Schizophrenia
11/23
11/23
NCT04671433 / 2020-002873-88: Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Completed
3
97
Europe, Canada, US, RoW
Genetic: AAV5-hRKp.RPGR, botaretigene sparoparvovec
Janssen Research & Development, LLC, Janssen Research & Development, LLC
X-Linked Retinitis Pigmentosa
09/24
09/24
NCT05169710 / 2021-002126-24: A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

Terminated
3
83
Europe, Canada, Japan, US
SEP-4199 CR 200 mg, SEP-4199 CR 400 mg, Placebo
Sumitomo Pharma America, Inc., Sunovion Pharmaceuticals Inc.
Depressive Episodes, Bipolar I Depression
10/23
10/23
MGT-RPGR-022, NCT04794101 / 2020-002255-37: Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Active, not recruiting
3
97
Europe, Canada, US, RoW
Genetic: AAV5-hRKp.RPGR Intermediate Dose, botaretigene sparoparvovec, Genetic: AAV5-hRKp.RPGR Low Dose
Janssen Research & Development, LLC, Janssen Research & Development, LLC
X-Linked Retinitis Pigmentosa
09/29
12/29
NCT06179108: Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

Active, not recruiting
2
350
US
LB-102
LB Pharmaceuticals Inc.
Schizophrenia
12/24
05/25
GION, NCT06178055: A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)

Active, not recruiting
2
75
US
KUS121 high dose, KUS121 low dose, Sham procedure
Kyoto Drug Discovery and Development Co., Ltd.
Central Retinal Artery Occlusion
03/25
12/25
NCT06116916: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema

Recruiting
2
150
Japan, US, RoW
KHK4951, Aflibercept Injection
Kyowa Kirin Co., Ltd.
Diabetic Macular Edema (DME)
11/25
12/25
NCT06116890: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Recruiting
2
180
Japan, US, RoW
KHK4951, Aflibercept Injection
Kyowa Kirin Co., Ltd.
Neovascular Age-Related Macular Degeneration (nAMD)
11/25
12/25
MAGIC, NCT05681884: Safety and Efficacy of Faricimab in Patients With NPDR

Active, not recruiting
2
179
US
Faricimab
Greater Houston Retina Research, Genentech, Inc.
Non-Proliferative Diabetic Retinopathy
03/26
04/26
NCT05230537: A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Recruiting
2
146
Europe, US, RoW
Iptacopan (LNP023), Placebo
Novartis Pharmaceuticals
Age-Related Macular Degeneration
10/26
10/26
PRISM, NCT05197270: 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

Recruiting
1/2
215
US
4D-150 IVT, Aflibercept IVT
4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
11/25
11/26
NCT05345769: Safety and Efficacy of AM712 in Patients with NAMD

Completed
1
21
US
AM712(ASKG712)
AffaMed Therapeutics Limited
Neovascular Age-related Macular Degeneration
11/24
11/24
NCT05057377: Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury

Completed
N/A
16
US
Standard Overground Assessment, Robotic Safety-Environment Assessment
The University of Texas Medical Branch, Galveston
Brain Injuries, Traumatic
08/22
08/22
RPNI, NCT04530526: Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface

Completed
N/A
25
US
Regenerative Peripheral Nerve Interface
University of Michigan Rogel Cancer Center, National Cancer Institute (NCI)
Post-Mastectomy Chronic Pain Syndrome
06/23
09/23
i-SIGHT, NCT05447650: Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration

Active, not recruiting
N/A
95
US
i-Lumen(TM) AMD, i-Lumen(TM) AMD Sham
i-Lumen Scientific, Inc.
Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration
06/25
06/25
NCT05934773: Post-Brain Injury Walking and Balance Recovery Program

Recruiting
N/A
20
US
KineAssist robotic treadmill
The University of Texas Medical Branch, Galveston, The Moody Foundation
Acquired Brain Injury, Stroke, Traumatic Brain Injury
12/25
12/25
NPC-QIC, NCT02852031: National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting
N/A
1000
Europe, Canada, US
Collaborative Learning Network
Children's Hospital Medical Center, Cincinnati
Hypoplastic Left Heart Syndrome (HLHS)
05/26
05/28
Brinkman, William B
PORTICO IDE, NCT02000115: Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial

Recruiting
N/A
1150
US, RoW
Portico transcatheter aortic valve, Commercially available transcatheter aortic valve
Abbott Medical Devices
Aortic Valve Stenosis
10/19
07/25
SURE-AVR, NCT02679404: Sorin Universal REgistry on Aortic Valve Replacement

Terminated
N/A
2758
Europe, Canada, US, RoW
Corcym S.r.l
Aortic Valve Disease, Aortic Stenosis
03/21
03/21
NCT01194362: A Study to Identify Differences in Gene Expression in Patients With Bicuspid and Tricuspid Valve Disease

Active, not recruiting
N/A
105
US
Baylor Research Institute
Aortic Valve Disease
12/22
12/22
TRIOMPHE, NCT04471909: NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

Recruiting
N/A
110
US, RoW
NEXUS Aortic Stent Graft System
Endospan Ltd.
Aortic Dissection, Aortic Aneurysm, Intramural Hematoma, Penetrating Aortic Ulcer
11/24
10/29
RelayBranch, NCT03214601: Early Feasibility Study of the Thoracic Stent-Graft System

Active, not recruiting
N/A
30
US
penetrating atherosclerotic ulcer, aorta branch cardiovascular implant, Relay Branch System, system, endovascular graft, aortic aneurysm treatment
Bolton Medical
Thoracic Aorta Aneurysm, Aneurysm, Ruptured, Aortic Aneurysm
09/23
08/28
ROSS, NCT06352671: Prospective Long-Term Outcomes of a Standardized Ross Procedure

Recruiting
N/A
225
US
Baylor Research Institute
Ross Procedure (Pulmonary Autograft Replacement)
12/25
01/26
NCT06305078: Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study

Active, not recruiting
N/A
30
US
Personalized ADHD Medication Experiment
Children's Hospital Medical Center, Cincinnati
Attention Deficit Hyperactivity Disorder
05/25
05/25
SSB 11-02, NCT02777528: Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)

Active, not recruiting
N/A
150
Japan, US
GORE® TAG® Thoracic Branch Endoprosthesis, Revascularization Procedure
W.L.Gore & Associates
Aortic Aneurysm, Thoracic, Aorta, Lesion
03/24
03/28
PERSEVERE, NCT05174767: - a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Active, not recruiting
N/A
115
US
AMDS
Artivion Inc., Syneos Health
Acute Aortic Dissection
12/23
12/29
TITAN:COMMENCE, NCT02860364: Comparing Hypothermic Temperatures During Hemiarch Surgery

Recruiting
N/A
282
Canada, US
Hypothermic circulatory arrest
Ottawa Heart Institute Research Corporation
Thoracic Aortic Disease
02/25
09/25
TITAN:SvS, NCT03536312: Treatment in Thoracic Aortic Aneurysm: Surgery vs Surveillance

Recruiting
N/A
610
Canada, US
Thoracic Aortic Surgery
Ottawa Heart Institute Research Corporation, University of Calgary
Ascending Aortic Aneurysm Enlargement, Ascending Aorta Aneurysm
05/25
05/26
PS-IDE, NCT03322033: Feasibility of Endovascular Repair of Ascending Aortic Pathologies

Recruiting
N/A
20
US
Valiant PS-IDE Stent Graft
Baylor Research Institute, Medtronic
Dissection of Thoracic Aorta
01/27
01/28

Download Options